Literature DB >> 21235576

HDAC6 regulates aggresome-autophagy degradation pathway of α-synuclein in response to MPP+-induced stress.

Min Su1, Ji-Jun Shi, Ya-Ping Yang, Jun Li, Yan-Ling Zhang, Jin Chen, Li-Fang Hu, Chun-Feng Liu.   

Abstract

Increasing evidence suggests that the ubiquitin-binding histone deacetylase-6 (HDAC6) plays an important role in the clearance of misfolded proteins by autophagy. In this study, we treated PC-12 cells over-expressing human mutant (A53T) α-synuclein (α-syn) and SH-SY5Y cells with MPP(+). It was found that HDAC6 expression significantly increased and mainly colocalized with α-syn in the perinuclear region to form aggresome-like bodies. HDAC6 deficiency blocked the formation of aggresome-like bodies and interfered with the autophagy in response to MPP(+)-induced stress. Moreover, misfolded α-syn accumulated into the nuclei, resulting in its reduced clearance, and finally, the number of apoptotic cells significantly increased. Taken together, HDAC6 participated in the degradation of MPP(+)-induced misfolded α-syn aggregates by regulating the aggresome-autophagy pathway. Understanding the mechanism may disclose potential therapeutic targets for synucleinopathies such as Parkinson's disease.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235576     DOI: 10.1111/j.1471-4159.2011.07180.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  26 in total

Review 1.  Application and interpretation of current autophagy inhibitors and activators.

Authors:  Ya-ping Yang; Li-fang Hu; Hui-fen Zheng; Cheng-jie Mao; Wei-dong Hu; Kang-ping Xiong; Fen Wang; Chun-feng Liu
Journal:  Acta Pharmacol Sin       Date:  2013-03-25       Impact factor: 6.150

2.  Isorhynchophylline Attenuates MPP+-Induced Apoptosis Through Endoplasmic Reticulum Stress- and Mitochondria-Dependent Pathways in PC12 Cells: Involvement of Antioxidant Activity.

Authors:  Xiao-Ming Li; Xiao-Jie Zhang; Miao-Xian Dong
Journal:  Neuromolecular Med       Date:  2017-08-18       Impact factor: 3.843

3.  Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism.

Authors:  Sachin Moonat; Amul J Sakharkar; Huaibo Zhang; Lei Tang; Subhash C Pandey
Journal:  Biol Psychiatry       Date:  2013-02-26       Impact factor: 13.382

4.  Uncoupling of Protein Aggregation and Neurodegeneration in a Mouse Amyotrophic Lateral Sclerosis Model.

Authors:  Joo-Yong Lee; Yoshiharu Kawaguchi; Ming Li; Meghan Kapur; Su Jin Choi; Hak-June Kim; Song-Yi Park; Haining Zhu; Tso-Pang Yao
Journal:  Neurodegener Dis       Date:  2015-09-12       Impact factor: 2.977

5.  Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease.

Authors:  Yu-Lin Guo; Wen-Jun Duan; Dan-Hua Lu; Xiao-Hui Ma; Xiao-Xiao Li; Zhao Li; Wei Bi; Hiroshi Kurihara; Hai-Zhi Liu; Yi-Fang Li; Rong-Rong He
Journal:  Acta Pharmacol Sin       Date:  2020-07-28       Impact factor: 6.150

6.  Genetics and epigenetics of Parkinson's disease.

Authors:  Fabio Coppedè
Journal:  ScientificWorldJournal       Date:  2012-05-01

7.  The E3 ubiquitin ligase seven in absentia homolog 1 may be a potential new therapeutic target for Parkinson's disease.

Authors:  Zeng-Lin Cai; Jing Xu; Shou-Ru Xue; Yuan-Yuan Liu; Yong-Jin Zhang; Xin-Zhi Zhang; Xuan Wang; Fang-Ping Wu; Xiao-Min Li
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

8.  Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation.

Authors:  Yue Huang; Fariba Chegini; Germaine Chua; Karen Murphy; Weiping Gai; Glenda M Halliday
Journal:  Transl Neurodegener       Date:  2012-01-13       Impact factor: 8.014

Review 9.  HDAC6 and ovarian cancer.

Authors:  Joshua Haakenson; Xiaohong Zhang
Journal:  Int J Mol Sci       Date:  2013-05-02       Impact factor: 5.923

Review 10.  HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?

Authors:  Claudia Simões-Pires; Vincent Zwick; Alessandra Nurisso; Esther Schenker; Pierre-Alain Carrupt; Muriel Cuendet
Journal:  Mol Neurodegener       Date:  2013-01-29       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.